Open AccessDipeptidyl-peptidase-4 inhibitors in type 2 diabetes and COVID-19: From a potential repurposed agent to a useful treatment option
Author(s) -
Awadhesh Kumar Singh,
Ritu Singh
Publication year - 2020
Publication title -
journal of diabetology
Language(s) - English
Resource type - Journals
eISSN - 2543-3288
pISSN - 2078-7685
DOI - 10.4103/jod.jod_53_20
Subject(s) - dipeptidyl peptidase 4 , type 2 diabetes , diabetes mellitus , medicine , hypoglycemia , covid-19 , coronavirus , vildagliptin , type 1 diabetes , pharmacology , intensive care medicine , disease , endocrinology , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom